v2.4.0.6
Consolidated Statements of Operations and Comprehensive Income (USD $)
In Thousands, except Per Share data, unless otherwise specified
 12 Months Ended
Dec. 30, 2011
Dec. 31, 2010
Jan. 01, 2010
Condensed Consolidated Statements of Operations and Comprehensive Income [Abstract]      
Sales $ 568,822 $ 533,425 $ 521,821
Cost of sales 388,469 359,844 355,402
Gross profit 180,353 173,581 166,419
Operating expenses:      
Selling, general and administrative expenses 72,548 64,510 70,294
Research, development and engineering costs, net 45,513 45,019 33,562
Electrochem Litigation charge (gain) 0 (9,500) 34,500
Intangible asset write-down 0 0 15,921
Other operating (income) expense, net 593 4,558 11,094
Total operating expenses 118,654 104,587 165,371
Operating income 61,699 68,994 1,048
Interest expense 16,928 18,519 20,071
Interest income (21) (10) (324)
(Gain) loss on cost method investments, net (4,232) 150 0
Other (income) expense 632 1,010 (522)
Income before provision for income taxes 48,392 49,325 (18,177)
Provision for income taxes 15,270 16,187 (9,176)
Net income 33,122 33,138 (9,001)
Earnings per share:      
Basic $ 1.42 $ 1.44 $ (0.39)
Diluted $ 1.40 $ 1.40 $ (0.39)
Weighted average shares outstanding:      
Basic 23,258 23,070 22,926
Diluted 23,636 23,802 22,926
Comprehensive income:      
Net income 33,122 33,138 (9,001)
Foreign currency translation gain (loss) (704) 7,896 4,562
Net change in cash flow hedges, net of tax (271) 1,027 (200)
Defined benefit plan liability adjustment, net of tax (566) (601) 862
Comprehensive income (loss) $ 31,581 $ 41,460 $ (3,777)